Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 2
Submit an article Journal homepage
441
Views
89
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia

Richard R. FurmanDivision of Hematology/Oncology, Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
,
Andres Forero-TorresComprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
,
Andrei ShustovDivision of Hematology, University of Washington, Seattle, WA, USA
&
Jonathan G. DrachmanSeattle Genetics, Inc., Bothell, WA, USA
Pages 228-235 | Received 07 Jul 2009, Accepted 26 Oct 2009, Published online: 28 Dec 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.